Slashdot Mirror
Google Has a Plan To Eliminate Mosquitoes Around the World (bloombergquint.com)
Zorro shares a report: Silicon Valley researchers are attacking flying bloodsuckers in California's Fresno County. It's the first salvo in an unlikely war for Google parent Alphabet: eradicating mosquito-borne diseases around the world. A white high-top Mercedes van winds its way through the suburban sprawl and strip malls as a swarm of male Aedes aegypti mosquitoes shoot out of a black plastic tube on the passenger-side window. These pests are tiny and, with a wingspan of just a few millimeters, all but invisible. "You hear that little beating sound?" says Kathleen Parkes, a spokesperson for Verily Life Sciences, a unit of Alphabet. She's trailing the van in her car, the windows down. "Like a duh-duh-duh? That's the release of the mosquitoes."
Jacob Crawford, a Verily senior scientist riding with Parkes, begins describing a mosquito-control technique with dazzling potential. These particular vermin, he explains, were bred in the ultra-high-tech surroundings of Verily's automated mosquito rearing system, 200 miles away in South San Francisco. They were infected with Wolbachia, a common bacterium. When those 80,000 lab-bred Wolbachia-infected, male mosquitoes mate with their counterpart females in the wild, the result is stealth annihilation: the offspring never hatch. Better make that 79,999. "One just hit the windshield," says Crawford. Mosquito-borne disease eradication is serious stuff for Alphabet, though it is just one of many of the company's forays into health care and life sciences.
Jacob Crawford, a Verily senior scientist riding with Parkes, begins describing a mosquito-control technique with dazzling potential. These particular vermin, he explains, were bred in the ultra-high-tech surroundings of Verily's automated mosquito rearing system, 200 miles away in South San Francisco. They were infected with Wolbachia, a common bacterium. When those 80,000 lab-bred Wolbachia-infected, male mosquitoes mate with their counterpart females in the wild, the result is stealth annihilation: the offspring never hatch. Better make that 79,999. "One just hit the windshield," says Crawford. Mosquito-borne disease eradication is serious stuff for Alphabet, though it is just one of many of the company's forays into health care and life sciences.
Zika wasn't a problem in South America until the Sharks lost the Stanley Cup in seven games.
I would rather a CRISPR-produced variety of mosquito that does not suck blood.
That is not a realistic goal. The female (only females suck blood) use the protein from the blood to make eggs. Non-blood-suckers would be at a reproductive disadvantage, and the modified gene would die out instead of spreading through the population.
A better goal is CRISPR-produced mosquitoes that don't transmit diseases. This would be no disadvantage to the mosquito, so would not die out.
And once we have proven this technique with mosquitoes, we can try it on humans.
Blood sucking human females are not a problem everywhere. Some countries don't have alimony.